MDGL
insider transactionsMADRIGAL PHARMACEUTICALS, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-1.9K
0 buy · 1.9K sell
Net value · 90d
-$952.0K
$0 in · $952.0K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
2
0 buy · 1.9K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
766 sh
Own New
-
Grant·A
Director
$0
454 sh
Own +0%
-
Grant·A
Director
$0
766 sh
Own New
-
Grant·A
Director
$0
454 sh
Own +17%
-
Grant·A
Director
$0
681 sh
Own New
-
Grant·A
Director
$0
404 sh
Own +42%
-
Sell·S
Chief Medical Officer · 10b5-1
$516.6K
1.0K sh · $495.74
Own -9%
-
Sell·S
Chief Medical Officer
$435.4K
844 sh · $515.90
Own -7%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Rebecca Taub | Grant A | 766 | $0 |
| Jun 17, 2026 | Rebecca Taub | Grant A | 454 | $0 |
| Jun 17, 2026 | James M Daly | Grant A | 766 | $0 |
| Jun 17, 2026 | James M Daly | Grant A | 454 | $0 |
| Jun 17, 2026 | Daniel J. Brennan | Grant A | 681 | $0 |
| Jun 17, 2026 | Daniel J. Brennan | Grant A | 404 | $0 |
| Jun 1, 2026 | David Soergel 10b5-1 | Sell S | 1.0K | $516.6K |
| May 18, 2026 | David Soergel | Sell S | 844 | $435.4K |
About MDGL insider trading
This page tracks insider transactions for MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.